Compare PGEN & AAUC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PGEN | AAUC |
|---|---|---|
| Founded | 1998 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.8B |
| IPO Year | 2013 | 2023 |
| Metric | PGEN | AAUC |
|---|---|---|
| Price | $6.39 | $19.86 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 5 |
| Target Price | $13.65 | ★ $29.45 |
| AVG Volume (30 Days) | ★ 4.6M | 312.7K |
| Earning Date | 11-12-2026 | 11-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.03 | N/A |
| Revenue | ★ $230,981,000.00 | N/A |
| Revenue This Year | $2,365.68 | $29.13 |
| Revenue Next Year | $85.75 | $58.95 |
| P/E Ratio | $220.17 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.04 | $14.60 |
| 52 Week High | $8.98 | $32.20 |
| Indicator | PGEN | AAUC |
|---|---|---|
| Relative Strength Index (RSI) | 36.29 | 41.79 |
| Support Level | $6.08 | $19.00 |
| Resistance Level | $7.44 | $31.85 |
| Average True Range (ATR) | 0.44 | 0.74 |
| MACD | -0.17 | 0.08 |
| Stochastic Oscillator | 2.37 | 33.26 |
Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.
Allied Gold Corp is a company focused on gold mining activities in Africa. Allied has three mines and several development and exploration projects in Africa, where it has operating experience. Operations are located in Cote d'Ivoire, Mali, and Ethiopia. The company expands and optimizes initiatives at existing operating mines, develops new mines, advances its exploration properties, and targets other consolidation opportunities, with a focus on Africa.